Cargando…

A pharmacovigilance study in the department of medicine of a university teaching hospital

The aim of the present study was to monitor adverse drug reactions (ADRs) in the Medicine out patient department (OPD) of a University Teaching Hospital. METHOD: A prospective evaluation of the ADRs reported in the Department of Medicine of our University Teaching Hospital over a period of 4-months...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Himanshu, Aqil, Mohammed, Imam, Faisal, Alam, Mohammad S., Kapur, Prem, Pillai, Krishna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155150/
https://www.ncbi.nlm.nih.gov/pubmed/25214918
_version_ 1782333544557707264
author Sharma, Himanshu
Aqil, Mohammed
Imam, Faisal
Alam, Mohammad S.
Kapur, Prem
Pillai, Krishna K.
author_facet Sharma, Himanshu
Aqil, Mohammed
Imam, Faisal
Alam, Mohammad S.
Kapur, Prem
Pillai, Krishna K.
author_sort Sharma, Himanshu
collection PubMed
description The aim of the present study was to monitor adverse drug reactions (ADRs) in the Medicine out patient department (OPD) of a University Teaching Hospital. METHOD: A prospective evaluation of the ADRs reported in the Department of Medicine of our University Teaching Hospital over a period of 4-months was conducted. RESULTS: During the study period, a total of 600 patients visited the Medicine OPD and 122 ADRs were reported. Out of 122 reports that were identified, a higher percentage of ADRs in males (52.4%) was observed as compared to females (47.5%). Of the 122 ADRs, 50 were found to be mild (41.0%), 49 moderate (40.2%), and 23 severe (18.2%). A total of 71 (58.0%) ADRs were observed in patients receiving 4 or more medications concurrently. Conversely 46 (37.7%) ADRs were detected in patients using 3 or less medicines. The largest number of reports were associated with antihypertensive therapy (39.3%), followed by antimicrobials (31.1%) and antidiabetics (10.7%). Amongst the organ systems affected, gastrointestinal ADRs constituted a major component (24.7%) followed by skin reactions (22.2%). On causality assessment, nearly 29.5% ADRs were considered as probable, 33.6% possible and 6.6% could not be categorised and were placed under unassessable. CONCLUSION: The present work is the maiden pharmacovigilance study conducted at our university teaching hospital. The data presented here will be useful in future, long term and more extensive ADR monitoring in the hospital and in promotion of rational prescribing and drug use in the hospital.
format Online
Article
Text
id pubmed-4155150
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41551502014-09-11 A pharmacovigilance study in the department of medicine of a university teaching hospital Sharma, Himanshu Aqil, Mohammed Imam, Faisal Alam, Mohammad S. Kapur, Prem Pillai, Krishna K. Pharm Pract (Granada) Original Research The aim of the present study was to monitor adverse drug reactions (ADRs) in the Medicine out patient department (OPD) of a University Teaching Hospital. METHOD: A prospective evaluation of the ADRs reported in the Department of Medicine of our University Teaching Hospital over a period of 4-months was conducted. RESULTS: During the study period, a total of 600 patients visited the Medicine OPD and 122 ADRs were reported. Out of 122 reports that were identified, a higher percentage of ADRs in males (52.4%) was observed as compared to females (47.5%). Of the 122 ADRs, 50 were found to be mild (41.0%), 49 moderate (40.2%), and 23 severe (18.2%). A total of 71 (58.0%) ADRs were observed in patients receiving 4 or more medications concurrently. Conversely 46 (37.7%) ADRs were detected in patients using 3 or less medicines. The largest number of reports were associated with antihypertensive therapy (39.3%), followed by antimicrobials (31.1%) and antidiabetics (10.7%). Amongst the organ systems affected, gastrointestinal ADRs constituted a major component (24.7%) followed by skin reactions (22.2%). On causality assessment, nearly 29.5% ADRs were considered as probable, 33.6% possible and 6.6% could not be categorised and were placed under unassessable. CONCLUSION: The present work is the maiden pharmacovigilance study conducted at our university teaching hospital. The data presented here will be useful in future, long term and more extensive ADR monitoring in the hospital and in promotion of rational prescribing and drug use in the hospital. Centro de Investigaciones y Publicaciones Farmaceuticas 2007 2007-04-02 /pmc/articles/PMC4155150/ /pubmed/25214918 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Sharma, Himanshu
Aqil, Mohammed
Imam, Faisal
Alam, Mohammad S.
Kapur, Prem
Pillai, Krishna K.
A pharmacovigilance study in the department of medicine of a university teaching hospital
title A pharmacovigilance study in the department of medicine of a university teaching hospital
title_full A pharmacovigilance study in the department of medicine of a university teaching hospital
title_fullStr A pharmacovigilance study in the department of medicine of a university teaching hospital
title_full_unstemmed A pharmacovigilance study in the department of medicine of a university teaching hospital
title_short A pharmacovigilance study in the department of medicine of a university teaching hospital
title_sort pharmacovigilance study in the department of medicine of a university teaching hospital
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155150/
https://www.ncbi.nlm.nih.gov/pubmed/25214918
work_keys_str_mv AT sharmahimanshu apharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT aqilmohammed apharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT imamfaisal apharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT alammohammads apharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT kapurprem apharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT pillaikrishnak apharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT sharmahimanshu pharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT aqilmohammed pharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT imamfaisal pharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT alammohammads pharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT kapurprem pharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital
AT pillaikrishnak pharmacovigilancestudyinthedepartmentofmedicineofauniversityteachinghospital